Coda Biotherapeutics racks up funding
South San Francisco-based Coda Biotherapeutics Inc, a preclinical-stage biopharmaceutical company, has raised a total of $34 million in funding. Versant Ventures was the lead investor in Coda's latest funding round.
5 November 2019•1 min read
